• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Europe faces tuberculosis ?time bomb? as new strains of the disease emerge

Shiloh

Editor, Senior Moderator
Source: http://www.theglobeandmail.com/life...h/europe-facing-tb-time-bomb/article13812203/


Europe faces tuberculosis ?time bomb? as new strains of the disease emerge
KATE KELLAND
Reuters
Published Friday, Aug. 16 2013, 12:09 PM EDT
Last updated Friday, Aug. 16 2013, 12:10 PM EDT

Europe is facing a ?time bomb? of rising costs to control tuberculosis as drug-resistant forms of the lung disease spread, a pioneering study has found.

Often thought of as a disease of the past or one restricted to marginalized communities, TB is already inflicting annual direct costs of more than ?500-million ($687-million) on the region and another ?5.3-billion in productivity losses.

The study, by health economists based in Germany, also suggests the economic burden of TB far outweighs the likely costs of investing in much-needed research to develop more effective medicines and vaccines ? something they said governments and the drug industry should do urgently..
 
Back
Top Bottom